InsidersTradesSigma
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by DOBMEIER ERIC, Chairman & CEO. Director active across 3 companies, notably Chinook Therapeutics, INC.. In total, 16 disclosures have been recorded. Total volume traded: €266k. The latest transaction was filed on 25 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations16 total
€60,9625,000 shares@ €12.192420.2% of flow
Common Stock
SEC:0001209191-22-032707:0·
Ideal exit: 19 Feb 2023 (T+270)
20,247 shares
Common Stock
SEC:0001209191-22-009561:0·
€12,35840,000 shares@ €0.308910.2% of flow
Common Stock
SEC:0001209191-21-071297·
€12,35840,000 shares@ €0.30894.1% of flow
Common Stock
SEC:0001209191-21-071297:0·
30,796 shares
Common Stock
SEC:0001209191-21-060113·
30,796 shares
Common Stock
SEC:0001209191-21-060113:0·
€20,4602,000 shares@ €10.2316.9% of flow
Common Stock
SEC:0001209191-21-057315·
Ideal exit: 17 Jun 2022 (T+270)
€20,4602,000 shares@ €10.236.8% of flow
Common Stock
SEC:0001209191-21-057315:0·
Ideal exit: 17 Jun 2022 (T+270)
€70,2057,000 shares@ €10.029358.1% of flow
Common Stock
SEC:0001209191-21-052605·
Ideal exit: 15 May 2022 (T+270)
€70,2057,000 shares@ €10.029323.2% of flow
Common Stock
SEC:0001209191-21-052605:0·
Ideal exit: 15 May 2022 (T+270)
€5,77520,000 shares@ €0.28874.8% of flow
Common Stock
SEC:0001209191-21-040659·
€5,77520,000 shares@ €0.28871.9% of flow
Common Stock
SEC:0001209191-21-040659:0·
011,000 shares0
Common Stock
SEC:0001140361-21-020435·
011,000 shares0
Common Stock
SEC:0001140361-21-020435:0·
€11,9561,000 shares@ €11.95639.9% of flow
Common Stock
SEC:0001209191-21-033574·
Ideal exit: 8 Feb 2022 (T+270)
€11,9561,000 shares@ €11.95634.0% of flow
Common Stock
SEC:0001209191-21-033574:0·
Ideal exit: 8 Feb 2022 (T+270)
16 of 16 declarations
About DOBMEIER ERIC
Eric Dobmeier is an executive at Chinook Therapeutics, Inc.
